Role of extracellular damage-associated molecular pattern molecules (DAMPs) as mediators of persistent pain

Progress in Molecular Biology and Translational Science

Volumn 131, Issue , 2015, Pages 251-279

  Kato, Jungo ^a   Svensson, Camilla I ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Pain DAMP HMGB1 S100B microRNA Heat shock proteins

Indexed keywords

ADENOSINE TRIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ADVANCED GLYCATION END PRODUCT RECEPTOR ANTAGONIST; CALGRANULIN A; CALGRANULIN B; CHEMICALS AND DRUGS; DAMAGE ASSOCIATED MOLECULAR PATTERN MOLECULE; DNA BINDING PROTEIN; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1; MICRORNA; MICRORNA LETHAL 7; MONOCYTE CHEMOTACTIC PROTEIN 1; PATTERN RECOGNITION RECEPTOR; PROTEIN S 100; PROTEIN S100B; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG; URIC ACID; PROTEIN; PURINE DERIVATIVE;

ANTIGEN PRESENTING CELL; ARTHRITIS; ARTICLE; BONE CANCER; CANCER PAIN; CELL DIFFERENTIATION; CELLULAR STRESS RESPONSE; CHRONIC PAIN; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HOST RESISTANCE; HUMAN; INFLAMMATION; INNATE IMMUNITY; INTRACELLULAR SIGNALING; NERVE INJURY; NEUROPATHIC PAIN; NOCICEPTION; NOCICEPTIVE PAIN; NONHUMAN; OXIDATION REDUCTION STATE; PAIN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TISSUE INJURY; TISSUE REPAIR; ANIMAL; EXTRACELLULAR SPACE; METABOLISM;

ANIMALS; EXTRACELLULAR SPACE; HUMANS; MICRORNAS; PAIN; PROTEINS; PURINES; RECEPTORS, PATTERN RECOGNITION;

EID: 84924513779     PISSN: 18771173     EISSN: 18780814     Source Type: Book Series    
DOI: 10.1016/bs.pmbts.2014.11.014     Document Type: Chapter

References (198)

1. M.E. Bianchi DAMPs, PAMPs and alarmins: all we need to know about danger J Leukoc Biol 81 2007 1 5
2. M.T. Lotze, H.J. Zeh, and A. Rubartelli The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity Immunol Rev 220 2007 60 81
3. P. Matzinger Tolerance, danger, and the extended family Annu Rev Immunol 12 1994 991 1045
4. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
5. J.K. Chan, J. Roth, and J.J. Oppenheim Alarmins: awaiting a clinical response J Clin Invest 122 2012 2711 2719
6. M. Keller, A. Ruegg, S. Werner, and H.D. Beer Active caspase-1 is a regulator of unconventional protein secretion Cell 132 2008 818 831
7. O. Hori, J. Brett, and T. Slattery The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system J Biol Chem 270 1995 25752 25761
8. J.S. Park, D. Svetkauskaite, and Q. He Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein J Biol Chem 279 2004 7370 7377
9. S. Ivanov, A.M. Dragoi, and X. Wang A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA Blood 110 2007 1970 1981
10. V.V. Orlova, E.Y. Choi, and C. Xie A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin EMBO J 26 2007 1129 1139
11. G.Y. Chen, J. Tang, P. Zheng, and Y. Liu CD24 and Siglec-10 selectively repress tissue damage-induced immune responses Science 323 2009 1722 1725
12. S.D. Yan, X. Chen, and J. Fu RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease Nature 382 1996 685 691
13. J.M. Ehrchen, C. Sunderkotter, D. Foell, T. Vogl, and J. Roth The endogenous Toll-like receptor 4 agonist S100A8/S100A9 (calprotectin) as innate amplifier of infection, autoimmunity, and cancer J Leukoc Biol 86 2009 557 566
14. R.M. Vabulas, P. Ahmad-Nejad, and C. da Costa Endocytosed HSP60s use Toll-like receptor 2 (TLR2) and TLR4 to activate the Toll/interleukin-1 receptor signaling pathway in innate immune cells J Biol Chem 276 2001 31332 31339
15. A. Zanin-Zhorov, G. Nussbaum, S. Franitza, I.R. Cohen, and O. Lider T cells respond to heat shock protein 60 via TLR2: activation of adhesion and inhibition of chemokine receptors FASEB J 17 2003 1567 1569
16. S. Basu, R.J. Binder, R. Suto, K.M. Anderson, and P.K. Srivastava Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway Int Immunol 12 2000 1539 1546
17. T. Becker, F.U. Hartl, and F. Wieland CD40, an extracellular receptor for binding and uptake of Hsp70-peptide complexes J Cell Biol 158 2002 1277 1285
18. H. Huang, J. Evankovich, and W. Yan Endogenous histones function as alarmins in sterile inflammatory liver injury through Toll-like receptor 9 in mice Hepatology 54 2011 999 1008
19. K. Kariko, H. Ni, J. Capodici, M. Lamphier, and D. Weissman mRNA is an endogenous ligand for Toll-like receptor 3 J Biol Chem 279 2004 12542 12550
20. C.K. Park, Z.Z. Xu, and T. Berta Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1 Neuron 82 2014 47 54
21. M.S. Lamphier, C.M. Sirois, A. Verma, D.T. Golenbock, and E. Latz TLR9 and the recognition of self and non-self nucleic acids Ann N Y Acad Sci 1082 2006 31 43
22. F. Martinon, A. Mayor, and J. Tschopp The inflammasomes: guardians of the body Annu Rev Immunol 27 2009 229 265
23. M.J. Bours, E.L. Swennen, F. Di Virgilio, B.N. Cronstein, and P.C. Dagnelie Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation Pharmacol Ther 112 2006 358 404
24. R. Liu-Bryan, P. Scott, A. Sydlaske, D.M. Rose, and R. Terkeltaub Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation Arthritis Rheum 52 2005 2936 2946
25. A. Halle, V. Hornung, and G.C. Petzold The NALP3 inflammasome is involved in the innate immune response to amyloid-beta Nat Immunol 9 2008 857 865
26. D. Jiang, J. Liang, and J. Fan Regulation of lung injury and repair by Toll-like receptors and hyaluronan Nat Med 11 2005 1173 1179
27. K. Yamasaki, J. Muto, and K.R. Taylor NLRP3/cryopyrin is necessary for interleukin-1beta (IL-1beta) release in response to hyaluronan, an endogenous trigger of inflammation in response to injury J Biol Chem 284 2009 12762 12771
28. G.B. Johnson, G.J. Brunn, Y. Kodaira, and J.L. Platt Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4 J Immunol 168 2002 5233 5239
29. S.T. Smiley, J.A. King, and W.W. Hancock Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4 J Immunol 167 2001 2887 2894
30. S.P. Gondokaryono, H. Ushio, and F. Niyonsaba The extra domain A of fibronectin stimulates murine mast cells via Toll-like receptor 4 J Leukoc Biol 82 2007 657 665
31. S. Chiba, M. Baghdadi, and H. Akiba Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1 Nat Immunol 13 2012 832 842
32. L. Cao, F.Y. Tanga, and J.A. Deleo The contributing role of CD14 in Toll-like receptor 4 dependent neuropathic pain Neuroscience 158 2009 896 903
33. D. Kim, M.A. Kim, and I.H. Cho A critical role of Toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity J Biol Chem 282 2007 14975 14983
34. V. Raghavendra, F.Y. Tanga, and J.A. DeLeo Complete Freunds adjuvant-induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS Eur J Neurosci 20 2004 467 473
35. F.Y. Tanga, N. Nutile-McMenemy, and J.A. DeLeo The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy Proc Natl Acad Sci USA 102 2005 5856 5861
36. U. Andersson, and K.J. Tracey HMGB1 is a therapeutic target for sterile inflammation and infection Annu Rev Immunol 29 2011 139 162
37. P. Scaffidi, T. Misteli, and M.E. Bianchi Release of chromatin protein HMGB1 by necrotic cells triggers inflammation Nature 418 2002 191 195
38. A. Asea, M. Rehli, and E. Kabingu Novel signal transduction pathway utilized by extracellular HSP70: role of Toll-like receptor (TLR) 2 and TLR4 J Biol Chem 277 2002 15028 15034
39. K. Ohashi, V. Burkart, S. Flohe, and H. Kolb Cutting edge: heat shock protein 60 is a putative endogenous ligand of the Toll-like receptor-4 complex J Immunol 164 2000 558 561
40. S.M. Lehmann, C Kruger, and B Park An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration Nat Neurosci 15 2012 827 835
41. K. Kariko, M. Buckstein, H. Ni, and D. Weissman Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA Immunity 23 2005 165 175
42. Q. Zhang, K. Itagaki, and C.J. Hauser Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase Shock 34 2010 55 59
43. S. Mariathasan, D.S. Weiss, and K. Newton Cryopyrin activates the inflammasome in response to toxins and ATP Nature 440 2006 228 232
44. A. Trautmann Extracellular ATP in the immune system: more than just a "danger signal" Sci Signal 2 2009 pe6
45. C. Termeer, F. Benedix, and J. Sleeman Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4 J Exp Med 195 2002 99 111
46. T. Ueda, and M. Yoshida HMGB proteins and transcriptional regulation Biochim Biophys Acta 1799 2010 114 118
47. U. Andersson, H. Erlandsson-Harris, H. Yang, and K.J. Tracey HMGB1 as a DNA-binding cytokine J Leukoc Biol 72 2002 1084 1091
48. H. Yang, M. Ochani, and J. Li Reversing established sepsis with antagonists of endogenous high-mobility group box 1 Proc Natl Acad Sci USA 101 2004 296 301
49. A. Tsung, J.R. Klune, and X. Zhang HMGB1 release induced by liver ischemia involves Toll-like receptor 4 dependent reactive oxygen species production and calcium-mediated signaling J Exp Med 204 2007 2913 2923
50. S. Gardella, C. Andrei, and D. Ferrera The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway EMBO Rep 3 2002 995 1001
51. H. Wang, O. Bloom, and M. Zhang HMG-1 as a late mediator of endotoxin lethality in mice Science 285 1999 248 251
52. R. Kang, R. Chen, and Q. Zhang HMGB1 in health and disease Mol Aspects Med 40c 2014 1 116
53. W. Jiang, and D.S. Pisetsky The role of IFN-alpha and nitric oxide in the release of HMGB1 by RAW 264.7 cells stimulated with polyinosinic-polycytidylic acid or lipopolysaccharide J Immunol 177 2006 3337 3343
54. B. Lu, D.J. Antoine, and K. Kwan JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation Proc Natl Acad Sci USA 111 2014 3068 3073
55. B. Rendon-Mitchell, M. Ochani, and J. Li IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism J Immunol 170 2003 3890 3897
56. J.R. Zhou, L.D. Zhang, and H.F. Wei Neuropeptide Y induces secretion of high-mobility group box 1 protein in mouse macrophage via PKC/ERK dependent pathway J Neuroimmunol 260 2013 55 59
57. B. Lu, T. Nakamura, and K. Inouye Novel role of PKR in inflammasome activation and HMGB1 release Nature 488 2012 670 674
58. I. Ito, J. Fukazawa, and M. Yoshida Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils J Biol Chem 282 2007 16336 16344
59. L. Ma, S.J. Kim, and K.I. Oh Calcium/calmodulin-dependent protein kinase is involved in the release of high mobility group box 1 via the interferon-beta signaling pathway Immune Netw 12 2012 148 154
60. Y.J. Oh, J.H. Youn, and Y. Ji HMGB1 is phosphorylated by classical protein kinase C and is secreted by a calcium-dependent mechanism J Immunol 182 2009 5800 5809
61. X. Zhang, D. Wheeler, and Y. Tang Calcium/calmodulin-dependent protein kinase (CaMK) IV mediates nucleocytoplasmic shuttling and release of HMGB1 during lipopolysaccharide stimulation of macrophages J Immunol 181 2008 5015 5023
62. E. Venereau, M. Casalgrandi, and M. Schiraldi Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release J Exp Med 209 2012 1519 1528
63. H. Yang, P. Lundback, and L. Ottosson Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1) Mol Med 18 2012 250 259
64. H.J. Huttunen, C. Fages, J. Kuja-Panula, A.J. Ridley, and H. Rauvala Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis Cancer Res 62 2002 4805 4811
65. H. Yang, H.S. Hreggvidsdottir, and K. Palmblad A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release Proc Natl Acad Sci USA 107 2010 11942 11947
66. L. Campana, L. Bosurgi, M.E. Bianchi, A.A. Manfredi, and P. Rovere-Querini Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells J Leukoc Biol 86 2009 609 615
67. H.S. Hreggvidsdottir, A.M. Lundberg, A.C. Aveberger, L. Klevenvall, U. Andersson, and H.E. Harris High mobility group box protein 1 (HMGB1)-partner molecule complexes enhance cytokine production by signaling through the partner molecule receptor Mol Med 18 2012 224 230
68. Y. Sha, J. Zmijewski, Z. Xu, and E. Abraham HMGB1 develops enhanced proinflammatory activity by binding to cytokines J Immunol 180 2008 2531 2537
69. M. Chacur, E.D. Milligan, and L.S. Gazda A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats Pain 94 2001 231 244
70. K.A. O'Connor, M.K. Hansen, and C. Rachal Pugh Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects Cytokine 24 2003 254 265
71. M. Shibasaki, M. Sasaki, and M. Miura Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury Pain 149 2010 514 521
72. J. Tanaka, Y. Seki, and H. Ishikura Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats Br J Pharmacol 170 2013 1233 1241
73. N.M. Agalave, M. Larsson, and S. Abdelmoaty Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis Pain 155 2014 1802 1813
74. P. Feldman, M.R. Due, M.S. Ripsch, R. Khanna, and F.A. White The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain J Neuroinflammation 9 2012 180
75. Y. Nakamura, N. Morioka, and H. Abe Neuropathic pain in rats with a partial sciatic nerve ligation is alleviated by intravenous injection of monoclonal antibody to high mobility group box-1 PLoS One 8 2013 e73640
76. K. Otoshi, S. Kikuchi, K. Kato, M. Sekiguchi, and S. Konno Anti-HMGB1 neutralization antibody improves pain-related behavior induced by application of autologous nucleus pulposus onto nerve roots in rats Spine (Phila Pa 1976) 36 2011 E692 E698
77. L. Mollica, F. De Marchis, and A. Spitaleri Glycyrrhizin binds to high-mobility group box 1 protein and inhibits its cytokine activities Chem Biol 14 2007 431 441
78. Y.M. Allette, M.R. Due, and S.M. Wilson Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain Brain Behav Immun 42 2014 169 177
79. J. Tanaka, K. Yamaguchi, and H. Ishikura Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis Neuropharmacology 79 2014 112 118
80. W. Tong, W. Wang, J. Huang, N. Ren, S.X. Wu, and Y.Q. Li Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain Biochem Biophys Res Commun 395 2010 572 576
81. P.C. Ren, Y. Zhang, and X.D. Zhang High-mobility group box 1 contributes to mechanical allodynia and spinal astrocytic activation in a mouse model of type 2 diabetes Brain Res Bull 88 2012 332 337
82. K. Abeyama, D.M. Stern, and Y. Ito The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism J Clin Invest 115 2005 1267 1274
83. T. Ito, K. Kawahara, and K. Okamoto Proteolytic cleavage of high mobility group box 1 protein by thrombin-thrombomodulin complexes Arterioscler Thromb Vasc Biol 28 2008 1825 1830
84. H. Rauvala, and R. Pihlaskari Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons J Biol Chem 262 1987 16625 16635
85. S. Guazzi, A. Strangio, A.T. Franzi, and M.E. Bianchi HMGB1, an architectural chromatin protein and extracellular signalling factor, has a spatially and temporally restricted expression pattern in mouse brain Gene Expr Patterns 3 2003 29 33
86. Y. Enokido, A. Yoshitake, H. Ito, and H. Okazawa Age-dependent change of HMGB1 and DNA double-strand break accumulation in mouse brain Biochem Biophys Res Commun 376 2008 128 133
87. P. Fang, M. Schachner, and Y.Q. Shen HMGB1 in development and diseases of the central nervous system Mol Neurobiol 45 2012 499 506
88. I.D. Kim, and J.K. Lee HMGB1-binding heptamer confers anti-inflammatory effects in primary microglia culture Exp Neurobiol 22 2013 301 307
89. S.W. Kim, Y. Jin, and J.H. Shin Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion Neurobiol Dis 46 2012 147 156
90. J.H. Shin, H.K. Lee, H.B. Lee, Y. Jin, and J.K. Lee Ethyl pyruvate inhibits HMGB1 phosphorylation and secretion in activated microglia and in the postischemic brain Neurosci Lett 558 2014 159 163
91. E. Zurolo, A. Iyer, and M. Maroso Activation of Toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development Brain 134 2011 1015 1032
92. M.D. Laird, J.S. Shields, and S. Sukumari-Ramesh High mobility group box protein-1 promotes cerebral edema after traumatic brain injury via activation of Toll-like receptor 4 Glia 62 2014 26 38
93. M. Pedrazzi, M. Patrone, and M. Passalacqua Selective proinflammatory activation of astrocytes by high-mobility group box 1 protein signaling J Immunol 179 2007 8525 8532
94. L.C. Grevers, T.J. de Vries, and T. Vogl S100A8 enhances osteoclastic bone resorption in vitro through activation of Toll-like receptor 4: implications for bone destruction in murine antigen-induced arthritis Arthritis Rheum 63 2011 1365 1375
95. S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis Nat Cell Biol 8 2006 1369 1375
96. D. Hoyaux, C. Decaestecker, and C.W. Heizmann S100 proteins in Corpora amylacea from normal human brain Brain Res 867 2000 280 288
97. I. Salama, P.S. Malone, F. Mihaimeed, and J.L. Jones A review of the S100 proteins in cancer Eur J Surg Oncol 34 2008 357 364
98. P.L. van Lent, L. Grevers, and A.B. Blom Myeloid-related proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis Ann Rheum Dis 67 2008 1750 1758
99. W.X. Yan, C. Armishaw, and J. Goyette Mast cell and monocyte recruitment by S100A12 and its hinge domain J Biol Chem 283 2008 13035 13043
100. R. Donato S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles Int J Biochem Cell Biol 33 2001 637 668
101. C.W. Heizmann, G. Fritz, and B.W. Schafer S100 proteins: structure, functions and pathology Front Biosci 7 2002 d1356 d1368
102. J. Pietzsch S100 proteins in health and disease Amino Acids 41 2011 755 760
103. J. Roth, T. Vogl, C. Sorg, and C. Sunderkotter Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules Trends Immunol 24 2003 155 158
104. R. Donato, B.R. Cannon, and G. Sorci Functions of S100 proteins Curr Mol Med 13 2013 24 57
105. D. Foell, H. Wittkowski, T. Vogl, and J. Roth S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules J Leukoc Biol 81 2007 28 37
106. J. Roth, M. Goebeler, and C. Sorg S100A8 and S100A9 in inflammatory diseases Lancet 357 2001 1041
107. C. Gebhardt, J. Nemeth, P. Angel, and J. Hess S100A8 and S100A9 in inflammation and cancer Biochem Pharmacol 72 2006 1622 1631
108. N. Hogg, C. Allen, and J. Edgeworth Monoclonal antibody 5.5 reacts with p8,14, a myeloid molecule associated with some vascular endothelium Eur J Immunol 19 1989 1053 1061
109. M.M. Wilkinson, A. Busuttil, C. Hayward, D.J. Brock, J.R. Dorin, and V. Van Heyningen Expression pattern of two related cystic fibrosis-associated calcium-binding proteins in normal and abnormal tissues J Cell Sci 91 pt 2 1988 221 230
110. G. Zwadlo, J. Bruggen, G. Gerhards, R. Schlegel, and C. Sorg Two calcium-binding proteins associated with specific stages of myeloid cell differentiation are expressed by subsets of macrophages in inflammatory tissues Clin Exp Immunol 72 1988 510 515
111. G. Fuellen, D. Foell, W. Nacken, C. Sorg, and C. Kerkhoff Absence of S100A12 in mouse: implications for RAGE-S100A12 interaction Trends Immunol 24 2003 622 624
112. T. Imamichi, I. Uchida, S.M. Wahl, and N. McCartney-Francis Expression and cloning of migration inhibitory factor-related protein (MRP)8 and MRP14 in arthritis-susceptible rats Biochem Biophys Res Commun 194 1993 819 825
113. Z. Yang, T. Tao, M.J. Raftery, P. Youssef, N. Di Girolamo, and C.L. Geczy Proinflammatory properties of the human S100 protein S100A12 J Leukoc Biol 69 2001 986 994
114. H. Fukumoto, M. Kakihana, and M. Suno Characterization of C6-10A glioma cells highly responsive to beta-adrenergic receptor agonist-induced NGF synthesis/secretion Glia 12 1994 151 160
115. L.J. Van Eldik, and D.B. Zimmer Secretion of S-100 from rat C6 glioma cells Brain Res 436 1987 367 370
116. A. Rammes, J. Roth, M. Goebeler, M. Klempt, M. Hartmann, and C. Sorg Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulin-dependent pathway J Biol Chem 272 1997 9496 9502
117. C.F. Urban, D. Ermert, and M. Schmid Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans PLoS Pathog 5 2009 e1000639
118. L.A. Altwegg, M. Neidhart, and M. Hersberger Myeloid-related protein 8/14 complex is released by monocytes and granulocytes at the site of coronary occlusion: a novel, early, and sensitive marker of acute coronary syndromes Eur Heart J 28 2007 941 948
119. J. Markowitz, and W.E. Carson III Review of S100A9 biology and its role in cancer Biochim Biophys Acta 1835 2013 100 109
120. J.G. Brun, G. Haland, H.J. Haga, M.K. Fagerhol, and R. Jonsson Effects of calprotectin in avridine-induced arthritis APMIS 103 1995 233 240
121. M. Ikemoto, H. Murayama, H. Itoh, M. Totani, and M. Fujita Intrinsic function of S100A8/A9 complex as an anti-inflammatory protein in liver injury induced by lipopolysaccharide in rats Clin Chim Acta 376 2007 197 204
122. R. Giorgi, R.L. Pagano, M.A. Dias, T. Aguiar-Passeti, C. Sorg, and M. Mariano Antinociceptive effect of the calcium-binding protein MRP-14 and the role played by neutrophils on the control of inflammatory pain J Leukoc Biol 64 1998 214 220
123. R.L. Pagano, M.A. Dias, C.S. Dale, and R. Giorgi Neutrophils and the calcium-binding protein MRP-14 mediate carrageenan-induced antinociception in mice Mediators Inflamm 11 2002 203 210
124. C.S. Dale, C. Altier, and N. Cenac Analgesic properties of S100A9 C-terminal domain: a mechanism dependent on calcium channel inhibition Fundam Clin Pharmacol 23 2009 427 438
125. 2) Br J Pharmacol 149 2006 374 384
126. C.C. Paccola, V.P. Gutierrez, I. Longo, L. Juliano, M.A. Juliano, and R. Giorgi Antinociceptive effect of the C-terminus of murine S100A9 protein on experimental neuropathic pain Peptides 29 2008 1806 1814
127. R. Donato, G. Sorci, and F. Riuzzi S100B's double life: intracellular regulator and extracellular signal Biochim Biophys Acta 1793 2009 1008 1022
128. R. Ciccarelli, P. Di Iorio, and V. Bruno Activation of A(1) adenosine or mGlu3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes Glia 27 1999 275 281
129. P.M. Whitaker-Azmitia, R. Murphy, and E.C. Azmitia Stimulation of astroglial 5-HT1A receptors releases the serotonergic growth factor, protein S-100, and alters astroglial morphology Brain Res 528 1990 155 158
130. M.M. Edwards, and S.R. Robinson TNF alpha affects the expression of GFAP and S100B: implications for Alzheimer's disease J Neural Transm 113 2006 1709 1715
131. D.F. de Souza, M.C. Leite, and A. Quincozes-Santos S100B secretion is stimulated by IL-1beta in glial cultures and hippocampal slices of rats: likely involvement of MAPK pathway J Neuroimmunol 206 2009 52 57
132. L.A. Pena, C.W. Brecher, and D.R. Marshak beta-Amyloid regulates gene expression of glial trophic substance S100 beta in C6 glioma and primary astrocyte cultures Brain Res Mol Brain Res 34 1995 118 126
133. S.S. Pinto, C. Gottfried, and A. Mendez Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology FEBS Lett 486 2000 203 207
134. R. Donato Intracellular and extracellular roles of S100 proteins Microsc Res Tech 60 2003 540 551
135. G. Ponath, C. Schettler, and F. Kaestner Autocrine S100B effects on astrocytes are mediated via RAGE J Neuroimmunol 184 2007 214 222
136. D.B. Zimmer, E.H. Cornwall, A. Landar, and W. Song The S100 protein family: history, function, and expression Brain Res Bull 37 1995 417 429
137. M.O. Dietrich, A.B. Tort, and D.V. Schaf Increase in serum S100B protein level after a swimming race Can J Appl Physiol 28 2003 710 716
138. A.G. Lam, T. Koppal, and K.T. Akama Mechanism of glial activation by S100B: involvement of the transcription factor NFkappaB Neurobiol Aging 22 2001 765 772
139. L.J. Van Eldik, and M.S. Wainwright The Janus face of glial-derived S100B: beneficial and detrimental functions in the brain Restor Neurol Neurosci 21 2003 97 108
140. M. Rothermundt, M. Peters, J.H. Prehn, and V. Arolt S100B in brain damage and neurodegeneration Microsc Res Tech 60 2003 614 632
141. M. Rothermundt, G. Ponath, T. Glaser, G. Hetzel, and V. Arolt S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia Neuropsychopharmacology 29 2004 1004 1011
142. S.A. Zanette, J.A. Dussan-Sarria, A. Souza, A. Deitos, I.L. Torres, and W. Caumo Higher serum S100B and BDNF levels are correlated with a lower pressure-pain threshold in fibromyalgia Mol Pain 10 2014 46
143. V.R. Ducourneau, T. Dolique, and S. Hachem-Delaunay Cancer pain is not necessarily correlated with spinal overexpression of reactive glia markers Pain 155 2014 275 291
144. Y. Shi, B.B. Gelman, J.G. Lisinicchia, and S.J. Tang Chronic-pain-associated astrocytic reaction in the spinal cord dorsal horn of human immunodeficiency virus-infected patients J Neurosci 32 2012 10833 10840
145. M.C. Canzobre, and H. Rios Pulpar tooth injury induces plastic changes in S100B positive astroglial cells in the trigeminal subnucleus caudalis Neurosci Lett 470 2010 71 75
146. Y. Lu, L. Zhu, and Y.J. Gao Pain-related aversion induces astrocytic reaction and proinflammatory cytokine expression in the anterior cingulate cortex in rats Brain Res Bull 84 2011 178 182
147. O. Sbai, T.S. Devi, and M.A. Melone RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion J Cell Sci 123 2010 4332 4339
148. M.E. Feder, and G.E. Hofmann Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology Annu Rev Physiol 61 1999 243 282
149. L. Sedger, and J. Ruby Heat shock response to vaccinia virus infection J Virol 68 1994 4685 4689
150. U. Zugel, and S.H. Kaufmann Immune response against heat shock proteins in infectious diseases Immunobiology 201 1999 22 35
151. F. Ritossa Discovery of the heat shock response Cell Stress Chaperon 1 1996 97 98
152. S.S. Mambula, and S.K. Calderwood Heat shock protein 70 is secreted from tumor cells by a nonclassical pathway involving lysosomal endosomes J Immunol 177 2006 7849 7857
153. Z. Li, A. Menoret, and P. Srivastava Roles of heat-shock proteins in antigen presentation and cross-presentation Curr Opin Immunol 14 2002 45 51
154. M.F. Tsan, and B. Gao Heat shock proteins and immune system J Leukoc Biol 85 2009 905 910
155. B. Gao, and M.F. Tsan Recombinant human heat shock protein 60 does not induce the release of tumor necrosis factor alpha from murine macrophages J Biol Chem 278 2003 22523 22529
156. B. Gao, and M.F. Tsan Endotoxin contamination in recombinant human heat shock protein 70 (Hsp70) preparation is responsible for the induction of tumor necrosis factor alpha release by murine macrophages J Biol Chem 278 2003 174 179
157. B. Gao, and M.F. Tsan Induction of cytokines by heat shock proteins and endotoxin in murine macrophages Biochem Biophys Res Commun 317 2004 1149 1154
158. A. Zanin-Zhorov, R. Bruck, and G. Tal Heat shock protein 60 inhibits Th1-mediated hepatitis model via innate regulation of Th1/Th2 transcription factors and cytokines J Immunol 174 2005 3227 3236
159. A. Zanin-Zhorov, G. Tal, and S. Shivtiel Heat shock protein 60 activates cytokine-associated negative regulator suppressor of cytokine signaling 3 in T cells: effects on signaling, chemotaxis, and inflammation J Immunol 175 2005 276 285
160. M. Costigan, R.J. Mannion, and G. Kendall Heat shock protein 27: developmental regulation and expression after peripheral nerve injury J Neurosci 18 1998 5891 5900
161. A. Osterloh, and M. Breloer Heat shock proteins: linking danger and pathogen recognition Med Microbiol Immunol 197 2008 1 8
162. J.L. Tidwell, L.J. Houenou, and M. Tytell Administration of Hsp70 in vivo inhibits motor and sensory neuron degeneration Cell Stress Chaperon 9 2004 88 98
163. K. Ohara, K. Shimizu, and S. Matsuura Toll-like receptor 4 signaling in trigeminal ganglion neurons contributes tongue-referred pain associated with tooth pulp inflammation J Neuroinflammation 10 2013 139
164. R. Pileggi, and G.R. Holland The expression of heat shock protein 70 in the dental pulp following trauma Dent Traumatol 25 2009 426 428
165. H.S. Sharma, S.F. Ali, R. Patnaik, S. Zimmermann-Meinzingen, A. Sharma, and D.F. Muresanu Cerebrolysin attenuates heat shock protein (HSP 72 KD) expression in the rat spinal cord following morphine dependence and withdrawal: possible new therapy for pain management Curr Neuropharmacol 9 2011 223 235
166. M.R. Hutchinson, K.M. Ramos, and L.C. Loram Evidence for a role of heat shock protein-90 in Toll like receptor 4 mediated pain enhancement in rats Neuroscience 164 2009 1821 1832
167. M.J. Urban, C. Li, and C. Yu Inhibiting heat-shock protein 90 reverses sensory hypoalgesia in diabetic mice ASN Neuro 2 2010 e00040
168. P. Fernyhough, A. Gallagher, and S.A. Averill Aberrant neurofilament phosphorylation in sensory neurons of rats with diabetic neuropathy Diabetes 48 1999 881 889
169. Y.J. Gao, and R.R. Ji Activation of JNK pathway in persistent pain Neurosci Lett 437 2008 180 183
170. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
171. L.P. Lim, N.C. Lau, and P. Garrett-Engele Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs Nature 433 2005 769 773
172. C. Braconi, J.C. Henry, T. Kogure, T. Schmittgen, and T. Patel The role of microRNAs in human liver cancers Semin Oncol 38 2011 752 763
173. P.S. Mitchell, R.K. Parkin, and E.M. Kroh Circulating microRNAs as stable blood-based markers for cancer detection Proc Natl Acad Sci USA 105 2008 10513 10518
174. H. Valadi, K. Ekstrom, A. Bossios, M. Sjostrand, J.J. Lee, and J.O. Lotvall Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells Nat Cell Biol 9 2007 654 659
175. X. Chen, H. Liang, J. Zhang, K. Zen, and C.Y. Zhang Secreted microRNAs: a new form of intercellular communication Trends Cell Biol 22 2012 125 132
176. M. Fabbri, A. Paone, and F. Calore MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response Proc Natl Acad Sci USA 109 2012 E2110 E2116
177. B.J. Reinhart, F.J. Slack, and M. Basson The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans Nature 403 2000 901 906
178. F. Heil, H. Hemmi, and H. Hochrein Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8 Science 303 2004 1526 1529
179. T. Liu, Z.Z. Xu, C.K. Park, T. Berta, and R.R. Ji Toll-like receptor 7 mediates pruritus Nat Neurosci 13 2010 1460 1462
180. H.H. Andersen, M. Duroux, and P. Gazerani MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions Neurobiol Dis 71c 2014 159 168
181. G. Burnstock Pathophysiology and therapeutic potential of purinergic signaling Pharmacol Rev 58 2006 58 86
182. D. Ferrari, P. Chiozzi, S. Falzoni, S. Hanau, and F. Di Virgilio Purinergic modulation of interleukin-1 beta release from microglial cells stimulated with bacterial endotoxin J Exp Med 185 1997 579 582
183. X. Wang, G. Arcuino, and T. Takano P2X7 receptor inhibition improves recovery after spinal cord injury Nat Med 10 2004 821 827
184. G. Burnstock Purinergic mechanisms and pain - an update Eur J Pharmacol 716 2013 24 40
185. I.M. Chiu, C.A. von Hehn, and C.J. Woolf Neurogenic inflammation and the peripheral nervous system in host defense and immunopathology Nat Neurosci 15 2012 1063 1067
186. D.C. Molliver, S.P. Cook, J.A. Carlsten, D.E. Wright, and E.W. McCleskey ATP and UTP excite sensory neurons and induce CREB phosphorylation through the metabotropic receptor, P2Y2 Eur J Neurosci 16 2002 1850 1860
187. M. Sanada, H. Yasuda, and M. Omatsu-Kanbe Increase in intracellular Ca(2 +) and calcitonin gene-related peptide release through metabotropic P2Y receptors in rat dorsal root ganglion neurons Neuroscience 111 2002 413 422
188. G.Y. Chen, and G. Nunez Sterile inflammation: sensing and reacting to damage Nat Rev Immunol 10 2010 826 837
189. H. Kono, C.J. Chen, F. Ontiveros, and K.L. Rock Uric acid promotes an acute inflammatory response to sterile cell death in mice J Clin Invest 120 2010 1939 1949
190. D.J. McCarty, and J.L. Hollander Identification of urate crystals in gouty synovial fluid Ann Intern Med 54 1961 452 460
191. R. Liu-Bryan Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome Immunol Cell Biol 88 2010 20 23
192. F. Martinon, V. Petrilli, A. Mayor, A. Tardivel, and J. Tschopp Gout-associated uric acid crystals activate the NALP3 inflammasome Nature 440 2006 237 241
193. M.D. Horowitz, L. Abbey, D.K. Sirota, and H. Spiera Intraarticular noninflammatory free urate suspension (urate milk) in 3 patients with painful joints J Rheumatol 17 1990 712 714
194. C. Hoffmeister, G. Trevisan, M.F. Rossato, S.M. de Oliveira, M.V. Gomez, and J. Ferreira Role of TRPV1 in nociception and edema induced by monosodium urate crystals in rats Pain 152 2011 1777 1788
195. C. Hoffmeister, M.A. Silva, and M.F. Rossato Participation of the TRPV1 receptor in the development of acute gout attacks Rheumatology (Oxford) 53 2014 240 249
196. P.C. Taylor, and M. Feldmann Anti-TNF biologic agents: still the therapy of choice for rheumatoid arthritis Nat Rev Rheumatol 5 2009 578 582
197. M. Feldmann, and R.N. Maini Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases Nat Med 9 2003 1245 1250
198. K. Reinhart, and W. Karzai Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned Crit Care Med 29 2001 S121 S125